Previous 10 | Next 10 |
Presentations at the 38th Annual European Association of Urology Congress Reinforce Low Surgical Retreatment of the UroLift ® System WAYNE, Pa., March 13, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today an...
2023-03-12 16:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
WAYNE, Pa., March 07, 2023 (GLOBE NEWSWIRE) -- Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023, at 12:00 p.m. (ET). ...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...
Teleflex Incorporated (TFX) Q4 2022 Earnings Conference Call February 23, 2023 08:00 AM ET Company Participants Lawrence Keusch - Vice President, Investor Relations & Strategy Development Liam Kelly - Chairman, President & Chief Executive Officer Thomas Powell ...
The following slide deck was published by Teleflex Incorporated in conjunction with their 2022 Q4 earnings call. For further details see: Teleflex Incorporated 2022 Q4 - Results - Earnings Call Presentation
Teleflex press release ( NYSE: TFX ): Q4 Non-GAAP EPS of $3.52 beats by $0.08 . Revenue of $758M (-0.5% Y/Y) misses by $2.29M . FY2023 Outlook : GAAP revenue growth guidance of 4.25% to 5.75% vs. consensus growth of 4.36%; Constant currency revenue growth guid...
WAYNE, Pa., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the fourth quarter ended December 31, 2022. Fourth quarter financial summary Revenues of $758.0 million, down...
Teleflex ( NYSE: TFX ) is scheduled to announce Q4 earnings results on Thursday, February 23rd, before market open. The consensus EPS Estimate is $3.44 (-4.4% Y/Y) and the consensus Revenue Estimate is $760.29M (-0.2% Y/Y). Over the last 2 years, TFX has beaten EPS estimates...
Teleflex ( NYSE: TFX ) said the U.S. Food and Drug Administration (FDA) granted 510(k) clearance to the Triumph Catheter, and the first clinical use of GuideLiner Coast Catheter, indicated for complex percutaneous coronary interventions The Triumph Catheter was designed in c...
News, Short Squeeze, Breakout and More Instantly...
WAYNE, Pa., July 24, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the establishment of the Teleflex Center for Antimicrobial Protection (TCAP) as a strategic branch of its Vascular Access business unit led by Chuck ...
WAYNE, Pa., July 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, August 1, 2024. To participate in the conference call, ple...
2024-07-09 10:00:05 ET Richard Newitter from Truist Financial issued a price target of $235.00 for TFX on 2024-07-09 08:48:00. The adjusted price target was set to $235.00. At the time of the announcement, TFX was trading at $211.73. The overall price target consensus is...